Ajou University repository

로봇-복강경하 부분신절제술을 받는 환자들에서 ulinastatin의 수술 후 신기능에 미치는 영향
  • 이보라
Citations

SCOPUS

0

Citation Export

Advisor
이숙영
Affiliation
아주대학교 일반대학원
Department
일반대학원 의학과
Publication Year
2018-02
Publisher
The Graduate School, Ajou University
Keyword
acute kidney injurynephrectomyreperfusion injuryrobotic surgical proceduresulinastatin
Description
학위논문(박사)--아주대학교 일반대학원 :의학과,2018. 2
Alternative Abstract
Background: Robot-assisted laparoscopic partial nephrectomy (RLPN) is an emerging technique for treating small renal masses. Although RLPN has many advantages, ischemic kidney injury is inevitable during renal artery clamping. The overall incidence of acute kidney injury (AKI) after partial nephrectomy has been reported to be up to 39%. Moreover, effective pharmacological protection against AKI after partial nephrectomy has not yet been demonstrated. Ulinastatin has been shown to protect the kidney from ischemia/reperfusion injury via its anti-inflammatory and anti-oxidant activities. Therefore, this study aimed to evaluate the effect of ulinastatin on postoperative kidney function in patients undergoing RLPN. Methods: In this randomized, double-blinded, placebo-controlled study, patients undergoing RLPN received either intravenous ulinastatin (100,000 units/10 kg; ulinastatin group, n=35) or the same volume of normal saline (control group, n=35) for 1 h starting 10 min before renal artery clamping. The primary outcome was incidence of postoperative AKI. Secondary outcomes were levels of serum creatinine, estimated glomerular filtration rate (eGFR), cystatin C, and inflammatory markers and were measured before operation and at 1, 24, 48, and 72 h postoperatively. Results: The incidence of postoperative AKI was 18% in the ulinastatin group, whereas it was 30% in the control group (p=0.251). No significant differences in postoperative changes of serum creatinine, eGFR, or cystatin C were observed between the two groups. Postoperative inflammatory markers including C-reactive protein, white blood cell count, and neutrophil percentage were significantly increased until 72 h after operation compared to the preoperative values in both groups, with no significant differences between the groups. Conclusions: Administration of ulinastatin (100,000 units/10 kg) during the warm ischemia and reperfusion periods did not show any beneficial effects on postoperative kidney function or inflammatory responses in patients undergoing RLPN.
Language
eng
URI
https://aurora.ajou.ac.kr/handle/2018.oak/19264
Journal URL
http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000026875
Type
Thesis
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Total Views & Downloads

File Download

  • There are no files associated with this item.